Alpha Bank AE

EURONEXT : ALPHA

Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France.

Information

Website
https://pharnext.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
France

Price

EUR 0.00

Symbol

ALPHA

Type

Common Stock

Previous Close

 :

0.00

52 Week Range

 :

0.00 - 3,550.00

Volume

 :

0.00

Average Volume

 :

0.00

High

 :

0.00

Low

 :

0.00

Change

 :

0.00

Percent change (%)

 :

0.00

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...